High rates of durable responses with anti-CD22 fractionated radioimmunotherapy: results of a multicenter, phase I/II study in non-Hodgkin's lymphoma.
暂无分享，去创建一个
D. Huglo | M. Pfreundschuh | L. Trümper | C. Kirsch | C. Bodet-Milin | F. Kraeber-Bodéré | R. Naumann | J. Chatal | D. Goldenberg | J. Harousseau | F. Morschhauser | N. Teoh | W. Wegener | S. le Gouill | Johannes Meller | H. Horne | J. Kropp | M. Petillon